Clinical Trial Update: Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating HPV vaccination versus placebo for treating refractory cutaneous warts is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Warts

Drugs mentioned

• HPV vaccination

Snippet

Sponsor: Western Institute for Veterans Research | Conditions: Warts | Phase 2, Phase 3 | Status: RECRUITING